Pharmacovigilance Risk Assessment Committee (PRAC)

PRAC is the committee at the European Medicines Agency (EMA) that is responsible for assessing and monitoring safety issues for human medicines.

PRAC’s recommendations are considered by the CHMP when it adopts opinions for centrally authorised medicines and referral procedures when it provides a recommendation on the use of a medicine in the Members States.

All Glossary Entries